When results actually start to appear, and when you should judge them
“It has been 2 weeks and nothing has changed” — this is what we hear most often in the consulting room. But if you lay out the time points the trials actually measured, 2 weeks is not a place from which to judge. We have written down, exactly as we verified it, when change is first measured, when it peaks, and when it starts to fade for each treatment. And why the mirror misses the change has been measured too.
The conclusion, first
Every treatment has a different timetable for results, and the differences are measured in months, not weeks. In a radiofrequency study of 20 Korean women, there was no significant improvement on clinician assessment at 4 weeks; it became significant at 12 weeks. Botulinum toxin appears within two days, but the peak of satisfaction was not at 2 weeks but at 2 to 3 months. Filler is at its fullest immediately afterwards and declines from there — dermal thickness increased 11% immediately and fell to 7% at 24 weeks. For the collagen-stimulating agents, human biopsies found no new collagen at 2 weeks, type III at 2 months, and type I at 3 to 4 months. And the most interesting finding of all — at the 90-day mark practitioners rated 92% as improved, while only 42% of patients themselves felt the same. At one year it flips completely the other way.
The timetable on a single page
Let us start by putting everything side by side. Each cell is a time point that a trial actually measured.
| Treatment | First measured change | Peak | Starts to decline |
|---|---|---|---|
| Botulinum toxin | 2.3 days on frowning · 2.8 days at rest | Effect 30 days · satisfaction 2 to 3 months | From 60 days — 25% at 120 days |
| Hyaluronic acid filler | Immediate (maximum right afterwards) | Immediately or at 30 days depending on the product | About 45% of initial volume retained at 24 weeks |
| Radiofrequency lifting | Instrument-measured elasticity at 4 weeks | Clinical assessment 12 weeks · peak 4 to 6 months | Slight decline at 7 to 10 months |
| Ultrasound lifting | — | 90 days (maximum quantitative lift) | Falls to 22 to 33% at one year |
| PN (Rejuran) | — | 16 weeks | Significance lost at 28 weeks |
| PDLLA (Juvelook) | 4 weeks (superior to control) | 24 weeks | Rapid decline after 24 weeks |
| PLLA | 3 weeks | 9 to 13 months | Attenuated at 25 months |
| PCL | No new collagen detected on 2-week biopsy | Still increasing at 4 years | No decline through 4 years |
| CaHA (diluted) | 2 months — type III collagen | Type I still rising at 7 months | Not measured |
The source and design for each entry are given in the sections below and in the references. Because this table gathers different studies into one place, you must not compare the cells directly — the outcome measures differ.
What to read from the table is that there is no single rule of “it takes so many weeks”. Toxin is two days; PCL is four years.
Botulinum toxin — it appears in two days, but 2 weeks is not the peak
This is the fastest treatment. Onset has been measured in a study of 41 Korean patients.
| Time point | What was measured |
|---|---|
| 2 days | 85.4% responded on frowning — but only 51.2% at rest |
| 7 days | Investigator-assessed response rate 74% |
| 30 days | Response rate 80% — the maximum |
| 57 to 85 days | Peak patient satisfaction (FACE-Q). “Looks younger” rated at −1.4 years |
| 90 days | Response rate 48% |
| 120 days | Response rate 25% |
Onset is from a phase IV study of 41 Korean patients (Arch Craniofac Surg 2018); the response rates are from the US prescribing information pooling two randomised controlled trials (405 patients on toxin versus 132 on placebo); the satisfaction trajectory is from Ascher et al., Aesthetic Surgery Journal 2020 (randomised · double-blind · placebo-controlled, 185 patients).
Two things follow from this.
First, lines at rest take longer to smooth out. On day two, 85% responded on frowning while the figure at rest was 51%. The moment when you stand still in front of the mirror and feel “nothing has changed” is genuinely there in the data.
Second, the practice of “reviewing and touching up at 2 weeks” has no evidence behind it. We looked, and there is no trial comparing a 2-week touch-up with a 4-week touch-up, and the 2024 Korean expert consensus statement contains no recommendation on the assessment time point either. What has been measured is that the peak of effect is at 30 days and the peak of satisfaction at 2 to 3 months. Two weeks is not the peak.
Filler — what “settling in” actually means
We often hear that “it takes 2 weeks to settle in”. While looking for the evidence behind that phrase, we found something interesting. There is no imaging study that measured volume at the 2-week time point at all. The existing studies all jump from “immediately → 30 days” or “immediately → 24 weeks”.
What has been measured is the following.
- Swelling generally resolves within a week. In the manufacturer's patient diary data, swelling after cheek treatment occurred in 85.7%, and 41% resolved in 1 to 3 days and 33% in 4 to 7 days. Bruising lasts longer, with 29.6% at 8 to 14 days.
- Volume is at its maximum immediately and declines from there. In a study using ultra-high-frequency ultrasound (13 patients), dermal thickness went from +11% immediately to +7.4% at 24 weeks, and three-dimensional volume was about 45% retained at 24 weeks relative to immediately after.
- That said, the direction is opposite depending on the product. In a randomised lip study (20 patients), one product fell from 20.56mm immediately to 19.56mm at 30 days, while another rose from 19.02 to 19.62.
So the accurate phrasing is “as the swelling goes down it becomes less full than it was at first”, not “it settles in”. And the figure of 2 weeks itself has never been validated. Our practice of seeing you again at around 2 weeks is a convention, and we say so.
The collagen-stimulating agents — when new collagen was seen in human tissue
When explaining boosters, the phrase “collagen starts forming from 4 to 6 weeks” is commonly used. We used it too. We could not find evidence confirming this from human biopsies.
The time points at which tissue was actually taken from humans are these.
| Material | Biopsy time point | Finding |
|---|---|---|
| PCL | 2 weeks | New collagen hard to find. Only carrier gel and macrophages observed. Dermal thickness +2.03% |
| CaHA | 2 months | Thin new type III collagen (p<0.01) |
| PLLA | 3 months | Type I increased statistically significantly |
| CaHA (diluted) | 4 months / 7 months | Type I p<0.05 → p<0.00001 — still rising |
| PCL | 1 year / 4 years | Dermal thickness +26.7% → +48.1% |
PCL is from Kim JS, Aesthetic Surgery Journal 2019 (13 Korean women, temple, untreated contralateral control). CaHA is from Zerbinati · Calligaro, CCID 2018 (5 patients, paired tissue). PLLA is from Goldberg et al., Dermatol Surg 2013 (14 patients, single-arm). Diluted CaHA is from Yutskovskaya · Kogan, JDD 2017 (20 patients, no control group).
How you read this matters. “Not visible at 2 weeks” does not mean “it does not work”; it means “it is still too early”. And for PLLA and PDLLA, human biopsies in the 4 to 8 week window do not exist at all. That window is a gap in the data, not an absence of effect. The common explanation of a “peak at 4 weeks” comes from mouse data, not human data.
We should also disclose one piece of conflicting data among the boosters. For PDLLA, a randomised · evaluator-blinded trial in 260 Asian patients reports that it was already superior to the control at 4 weeks and declined rapidly after 24 weeks. A 40-patient study with no control group, by contrast, reports continued improvement from 8 weeks to 24 weeks. The former study is the stronger design.
Lifting — at 4 weeks it is still nothing
The radiofrequency study of 20 Korean women conducted with blinded evaluators is the most practical piece of data in this article.
| Time point | Clinician assessment | Instrument-measured elasticity |
|---|---|---|
| 4 weeks | No significant improvement | Significantly improved (p<0.01) |
| 12 weeks | Significant (p<0.05) | Significant (p<0.01) |
| 24 weeks | Maintained | Significant (p<0.01) |
Shin JM et al., Cosmetics 2024;11(3):71. Skin types III to IV, mean age 47.95, photographs assessed by 3 blinded dermatologists. We also state that this was a single-arm study with no control group.
The most interesting thing in this table is that the two values in the 4-week row disagree with each other. By instrument it has already improved, but the human eye cannot see it yet. The physical properties of the skin change first and appearance follows later.
The other data point the same way.
- 39-patient multicentre study: improvement rate 84.6% at 30 days → 92.3% at 90 days
- Two independent studies report a peak at 4 to 6 months. One reports a slight decline at 7 to 10 months
- Ultrasound lifting: quantitative lift is maximal at 90 days and falls to 22 to 33% at one year
So the point at which judgement is reasonable is 3 months, and the peak is later still. Being disappointed at 4 weeks is natural, but on the evidence it is not yet the place from which to judge.
Patients and practitioners see different things — and it flips depending on when you look
This section is the most surprising part of the article. How differently patients and observers see the same treatment at the same time point has been measured.
| Study | Time point | Observer | Patient themselves |
|---|---|---|---|
| Ultrasound lifting, 16 studies | 90 days | 92% improved | 42% improved |
| Ultrasound lifting, 20 patients | 1 year | 43% improved | Satisfaction 95 to 100% |
| Facelift, 48 patients | — | Blinded observers 4.51±1.20 years | Self-estimate 7.3 years |
| Toxin, 57 patients | 2 weeks | (not assessed) | Judged themselves to look 5.6 years younger |
The ultrasound pooling is from Contini et al., IJERPH 2023 (16 studies). The one-year data are from Werschler · Werschler, JCAD 2016 (20 patients). The facelift data are from Du H et al., Aesthetic Plast Surg 2024 (48 Chinese women). The toxin data are from Chang et al., Aesthetic Surgery Journal 2016 (57 patients, measured at 2 weeks only).
The direction flips completely depending on when you look.
- At 90 days patients see less than observers (42% versus 92%). That is why they are disappointed early.
- At one year patients see more than observers (95% versus 43%). That is why they remain satisfied after the effect has entirely worn off.
These two lines explain almost every misunderstanding in the consulting room. Early on it feels like “it did not work”, and later it feels like “it is still fine”. That is why we take photographs. Photographs are more accurate than memory and mirrors.
Why the mirror misses the change has been measured
There is experimental evidence behind the phrase “I see it every day so I cannot tell”.
Visual adaptation. In one experiment, 48 women were split into two groups and repeatedly shown either very full lips or very thin lips. Within minutes, the standard for “attractive” shifted towards whichever they had been exposed to. Ratings of “natural”, however, did not shift.
The mirror effect. In a study of 198 people asked to choose between a photograph of their own face and its left-right reversed version placed side by side, 56.6% preferred the mirror image of their own selfie, while for photographs of other people the majority preferred the true image. You see yourself as a mirror image, while we and your family see you as the true image. In effect you are looking at different faces.
So you cannot catch the change with a mirror every day. Two photographs from the same position, in the same lighting, at the same angle are far more accurate. We strongly recommend having a photograph taken before treatment — it is the only way to determine later whether things really did change.
We would add that a phase of “looking worse at first and then getting better” has never been measured for any treatment. What has been measured is the opposite — filler looks fuller immediately than it really is, and lifting is recorded early on not as ‘worse’ but as ‘not yet’.
Does adding more sessions make results appear sooner
To answer first: we could not find a trial comparing the ‘time of onset’ between one session and several. What has been measured in relation to the number of sessions is magnitude, not timing.
- In a microneedling radiofrequency study (24 patients analysed), there was a positive correlation between the number of sessions · total energy and volume change (r=0.676, p<0.001). That said, it was not a comparison of schedules.
- In a study completed by 9 Korean patients (3 sessions 4 weeks apart), wrinkles became significant from 8 weeks (after the second session), and every measure was at its best 6 months after the final session. — meaning things keep improving even after the course has ended.
And satisfaction did not rise with larger amounts either. Satisfaction by toxin dose was 60% at 40 units → 51% at 60 units → 39% at 80 units. Dissatisfaction is linked more often with overcorrection than with undercorrection. We have written about this topic in detail in what is the difference between a natural face and an artificial one?.
What we tell patients at Miso Clinic
- We take photographs before treatment. Mirrors and memory cannot settle the question. This is the single most practical measure.
- We give a different time point for each treatment. Toxin two days · radiofrequency 3 months · the collagen-stimulating agents later than that. There is no single answer.
- You should not judge radiofrequency and ultrasound before 3 months. At 4 weeks there was no significant difference even to a clinician's eye.
- For toxin, reviewing at around a month rather than at 2 weeks fits the evidence. The peak of effect is at 30 days. That said, if something is clearly under-treated we will see you before then.
- With filler, it becomes less full than it was at first as the swelling goes down. If you are satisfied immediately afterwards, it may in fact be overcorrected.
- We do not add more straight away just because it looks insufficient. Dose and satisfaction were not proportional.
- We distinguish between “it is still early” and “it did not work”. The numbers in this article are the basis for that distinction.
The redness and swelling of the first few days after treatment, and when you should contact us, are covered separately in aftercare following RF (radiofrequency) treatment and the order in which bruising and swelling pass after treatment. Number of sessions and duration are in number of sessions and how long results last.
In summary
- What we confirmed — in the radiofrequency study of 20 Korean women, there was no significant improvement on clinician assessment at 4 weeks and it became significant at 12 weeks. In the same study, instrument-measured elasticity improved from 4 weeks.
- What we confirmed — the peak of toxin's effect is at 30 days, and the peak of satisfaction at 2 to 3 months. Two weeks is not the peak.
- What we confirmed — on human biopsy, no new collagen was detected at 2 weeks, with type III confirmed at 2 months and type I at 3 to 4 months.
- What we confirmed — at 90 days, practitioners 92% versus patients 42%; at one year, observers 43% versus patients 95 to 100%. The two views flip depending on when you look.
- What we could not find evidence for — “filler settles in at 2 weeks”, “judge toxin at 2 weeks”, “collagen forms from 4 to 6 weeks” (no human evidence, mouse data), “more sessions make it appear sooner”.
So the conclusion of this article is not “wait a little longer” but “each treatment has a set point at which to judge, and it is better to know it before you start”. Waiting is unsettling when it is vague, but when it is set at 3 months, that is a plan.
Frequently asked questions
It has been 2 weeks since my treatment and nothing has changed. Has it failed?
Two weeks is not the point at which to judge. In a radiofrequency study of 20 Korean women conducted with blinded evaluators, there was still no significant improvement on clinician assessment at 4 weeks; it became significant at 12 weeks and was maintained through 24 weeks. What is interesting is that in the same study, instrument-measured elasticity improved significantly from 4 weeks — the physical properties of the skin change first and appearance follows later. The collagen-stimulating agents are slower still: on human biopsy, no new collagen was detected at 2 weeks.
When is Botox at its best? Do I need a touch-up at 2 weeks?
In a study of 41 Korean patients, onset was at a median of 2.3 days on frowning and 2.8 days at rest. The peak response rate is at 30 days (80%), and the peak of patient satisfaction in a randomised placebo-controlled study was at 57 to 85 days, that is, 2 to 3 months. As for the practice of “reviewing and touching up at 2 weeks”, we could not find a trial comparing a 2-week touch-up with a 4-week one, and the 2024 Korean expert consensus statement contains no recommendation on the assessment time point either. If something is clearly under-treated we will see you before then, but on the evidence around a month is right.
They say filler takes 2 weeks to settle in — is that right?
We could not find a study validating the figure of “2 weeks”. There is no imaging study at all that measured volume at the 2-week point after injection; the existing studies jump from immediately afterwards to 30 days or 24 weeks. What has been measured is that swelling generally resolves within a week (74% for cheek treatment), bruising can last 8 to 14 days, and volume is at its maximum immediately and declines from there. Dermal thickness increased 11% immediately and fell to 7.4% at 24 weeks. So the accurate phrasing is not “it settles in” but “it becomes less full than it was at first”.
When does collagen start forming?
It is commonly said to be “from 4 to 6 weeks”, but we could not find human biopsy evidence for that. What has been confirmed in humans is that when PCL was biopsied at 2 weeks new collagen was hard to find; CaHA showed type III at 2 months and PLLA showed a statistically significant increase in type I at 3 months. Diluted CaHA was significant at 4 months and still rising at 7 months, and PCL showed dermal thickness of +26.7% at 1 year and +48.1% at 4 years. The explanation of a “peak at 4 weeks” comes from mouse data, not human data.
I do not think I look any different, but people around me say I have improved. Why is that?
This is a measured phenomenon. In pooled data from 16 ultrasound lifting studies, at the same 90-day point practitioners rated 92% as improved while patient self-assessment was 42%. Conversely, in a study looking at the one-year point (20 patients), blinded observers judged only 43% as improved while patient satisfaction was 95 to 100%. In other words, patients see less early on and more later. Visual adaptation also plays a part — in an experiment with 48 women, just a few minutes of repeated exposure shifted the standard for “attractive”. If you look in the mirror every day, you miss the change.
Why do I look different in photographs than in the mirror?
This is called the mirror effect and it has been measured. In a study of 198 people asked to choose between a photograph of their own face and its left-right reversed version placed side by side, 56.6% preferred the mirror image of their own selfie, while for photographs of other people the majority preferred the true image. You have seen yourself as a mirror image your whole life, while we and your family see you as the true image. That is why, when judging results, comparing two photographs from the same position, in the same lighting, at the same angle is the most accurate approach.
Will more sessions make the results come sooner?
We could not find a trial comparing the “time of onset” between one session and several. What has been measured is magnitude, not timing — in a microneedling radiofrequency study there was a positive correlation between the number of sessions and total energy and volume change (r=0.676). In a Korean study of 3 sessions, every measure was at its best 6 months after the final session. In other words, things keep improving after the course has ended. That said, more is not more satisfying: satisfaction by toxin dose was 60% at 40 units, 51% at 60 units and 39% at 80 units.
Can things actually look worse at first and then get better?
We could not find a trial for any treatment measuring a validated outcome score that dropped below baseline early on and then improved. What has been measured points the other way — filler looks fuller immediately than it really is (dermal thickness +11% immediately versus +7.4% at 24 weeks), and lifting and boosters are recorded early on not as “worse” but as “not yet”. There is, however, one genuine discrepancy with toxin. On day two, 85.4% responded on frowning while only 51.2% responded at rest — the moment when you stand expressionless in front of the mirror and feel “nothing has changed” is genuinely there in the data.
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Botulinum toxin onset is from Archives of Craniofacial Surgery 2018 (41 Korean patients, phase IV single-arm, Asan Medical Center: median 2.3 days on frowning · 2.8 days at rest). The response-rate curve is from the US prescribing information (two identically designed randomised controlled trials pooled, 405 patients on toxin versus 132 on placebo: 7 days 74% · 30 days 80% · 60 days 70% · 90 days 48% · 120 days 25%), and the satisfaction trajectory is from Ascher B et al., Aesthetic Surgery Journal 2020;40(9):1000 (phase III randomised · double-blind · placebo-controlled, 185 patients, FACE-Q measured at days 8, 15, 29, 57, 85, 113, 148 and 183 — peak at 57 to 85 days).
- The filler swelling data are from the patient diary in the manufacturer's instructions for use (265 patients, first cheek treatment: swelling 85.7%, 1 to 3 days 41.0% · 4 to 7 days 33.0%; bruising 8 to 14 days 29.6%). The volume changes are from Salvia et al., Diagnostics 2023;13(17):2761 (13 patients, ultra-high-frequency ultrasound + three-dimensional imaging: dermal thickness +11% immediately → +7.4% at 24 weeks, volume about 45% retained at 24 weeks) and Germani M et al. (randomised controlled lip study, 20 patients — the direction to 30 days is opposite depending on the product). We could not find an imaging study measuring volume at the 2-week point after injection.
- The human biopsies are Kim JS, Aesthetic Surgery Journal 2019 (PCL, 13 Korean women, temple, 2 weeks · 1 year · 4 years), Zerbinati N · Calligaro A, CCID 2018 (CaHA, 5 patients, paired tissue taken during abdominoplasty, 2 months), Goldberg D et al., Dermatologic Surgery 2013 (PLLA, 14 patients, single-arm open-label, 3 · 6 · 12 months) and Yutskovskaya YA · Kogan EA, JDD 2017 (diluted CaHA, 20 patients, no control group, 4 · 7 months). For PLLA and PDLLA, human biopsies in the 4 to 8 week window do not exist. The “peak at 4 weeks” comes from mouse data (Giang et al., Aesthetic Plast Surg 2025).
- Conflicting data on PDLLA — Ting et al., Aesthetic Surgery Journal 2024;44(12):NP898 (randomised · evaluator-blinded · multicentre, 260 patients, all Asian, single injection) reports that it was already superior to the hyaluronic acid control at 4 weeks and declined rapidly after 24 weeks. By contrast, Seo SB et al., Aesthetic Plast Surg 2026 (40 patients, no control group) reports a continued rise from 8 weeks to 24 weeks. The former is the stronger design.
- The radiofrequency time-point data are from Shin JM et al., Cosmetics 2024;11(3):71 (20 Korean women, evaluator-blinded, single-arm with no control group: clinician assessment not significant at 4 weeks · significant at 12 and 24 weeks, instrument-measured elasticity from 4 weeks at p<0.01), Cureus 2026 (prospective multicentre, 39 patients: 30 days 84.6% → 90 days 92.3%), Fitzpatrick 2003 (86 patients) and Edwards 2013 (64 patients, peak at 4 to 6 months · slight decline at 7 to 10 months).
- Ultrasound lifting is from Contini M et al. (corresponding author Schortinghuis J), IJERPH 2023;20(2):1522 (16 studies: at 90 days practitioners 92% versus patients 42%, self-assessment 42% at 90 days → 53% at 360 days) and Werschler WP · Werschler PS, JCAD 2016 (prospective open-label, 20 patients: maximum quantitative lift at 90 days, falling to 22 to 33% at one year, blinded assessment at one year 43% (6/14) versus patient satisfaction 95 to 100%).
- The PN data are from Lee YJ et al., J Dermatolog Treat 2022;33(1):254-260 (randomised · double-blind · split-face, 27 patients, 3 sessions 2 weeks apart, followed to 28 weeks). The overall conclusion of that trial was that “there was no significant difference between the PN group and the non-cross-linked hyaluronic acid control group in VAS and GAIS improvement”, and the advantage at 16 weeks is a single time-point finding within it.
- The difference in perception between patients and observers is from the studies above plus Du H et al., Aesthetic Plastic Surgery 2024 (facelift, 48 Chinese women: blinded observers 4.51±1.20 years · artificial intelligence 3.75±3.93 years versus patient self-estimate 7.3 years) and Chang BL et al., Aesthetic Surgery Journal 2016 (toxin, 57 patients, measured at 2 weeks only, self-estimate 5.6 years).
- Visual adaptation is from Goldie K et al., CCID 2021;14 (48 women, mean age 22.5, randomised allocation, lip volume manipulated — attractiveness ratings shifted but ratings of ‘naturalness’ did not). The mirror effect is from Al-Bitar ZB et al., Maxillofac Plast Reconstr Surg 2023 (198 people: 56.6% preferred the mirror image of their own selfie, while the majority preferred the true image for photographs of others).
- The data on number of sessions are from Nguyen et al. 2025 (microneedling radiofrequency, volume analysis in 24 patients, total energy-volume correlation r=0.676, p<0.001 — not a comparison of schedules) and Kim KE et al. 2023 (9 Korean patients completed, 3 sessions 4 weeks apart, every measure at its best 6 months after the final session). The dose-satisfaction data are a citation via a review article, and we could not verify the original trial directly.
- What we recorded as “we could not find evidence” — filler settling at 2 weeks, judging · touching up toxin at 2 weeks, collagen forming at 4 to 6 weeks (human evidence), the relationship between number of sessions and time of onset, and a phase of “getting worse then better”. We could not find prospective decision-regret research in the aesthetic injectables field either.
- This article does not guarantee the efficacy of any particular treatment. The course varies with each individual's condition, and consultation through an examination is necessary.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia